Establishment and evaluation of 2 monoclonal antibodies against oxidized apolipoprotein A-I (apoA-I) and its application to determine blood oxidized apoA-I levels

Clinica Chimica Acta

Volumn 378, Issue 1-2, 2007, Pages 105-111

  Ueda, Masashi ^a   Hayase, Yasuyuki ^a   Mashiba, Shinichi ^a  

^a Ikagaku Co Ltd   (Japan)

Author keywords

Apolipoprotein A I; ELISA; Monoclonal antibody; Oxidative stress; Oxidized apolipoprotein A I

Indexed keywords

ANTIGEN; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HYDROGEN PEROXIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7D3; MONOCLONAL ANTIBODY 98A7; MONOCLONAL ANTIBODY H2F8; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; INFLAMMATORY DISEASE; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES, MONOCLONAL; APOLIPOPROTEIN A-I; CHLORAMINES; CHROMATOGRAPHY, AFFINITY; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; TOSYL COMPOUNDS;

EID: 33846894759     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.11.002     Document Type: Article

References (29)

1. Rothblat G.H., Mahlberg F.H., Johnson W.J., and Phillips M.C. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J Lipid Res 33 (1992) 1091-1097
2. Chambenoit O., Hamon Y., Marguet D., Rigneault H., Rosseneu M., and Chimini G. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1. J Biol Chem 276 (2001) 9955-9960
3. Mashima R., Yamamoto Y., and Yoshikawa S. Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-1: purification of the hydroperoxide-reducing proteins from human blood plasma. J Lipid Res 39 (1998) 1133-1140
4. Garner B., Waldeck R., Witting P.K., Rye K.A., and Stocker R. Oxidation of high density lipoprotein. J Biol Chem 273 (1998) 6088-6095
5. Garner B., Witting P.K., Waldeck R., Christison J.K., Raftery M., and Stocker R. Oxidation of high density lipoproteins. J Biol Chem 273 (1998) 6080-6087
6. Sigalov A.B., and Stern L.J. Oxidation of methionine residues affects the structure and stability of apolipoprotein A-1 in reconstituted high density lipoprotein particles. Chem Phys Lipids 113 (2001) 133-146
7. Francis G.A., Oram J.F., Heinecke J.W., and Bierman E.L. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry 35 (1996) 15188-15197
8. Wang W.Q., Merriam D.L., Moses A.S., and Francis G.A. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein A1-A2 heterodimers. J Biol Chem 273 (1998) 17391-17398
9. Francis G.A. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim Biophys Acta 1483 (2000) 217-235
10. Macdonald D.L., Terry T.L., Agellon L.B., Nation P.N., and Ftancis G.A. Administration of tyrosyl radical oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 23 (2003) 1583-1588
11. Pankhurst G., Wang X.L., Wilcken D.E., et al. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. J Lipid Res 44 (2003) 349-355
12. Cogny A., Paul J.L., Surbled B., Atger V., Lenoble M., and Moatti N. Oxidative modofication of high-density lipoprotein 3 induced by human polymorphonuclear neutrophils. Eur J Biochem 259 (1999) 32-39
13. Zheng L., Nukuna B., Brennan M.L., et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114 (2004) 529-541
14. Nakajima T., Sakagishi Y., Katahira T., et al. Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL. Biochem Biophys Res Commun 217 (1995) 407-411
15. Nakajima T., Origuchi N., Matsunaga T., et al. Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann Clin Biochem 37 (2000) 179-186
16. Nakajima T., Matsunaga T., Kawai S., et al. Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasma. Ann Clin Biochem 41 (2004) 309-315
17. Nakano T., and Nagata A. Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody. J Lab Clin Med 141 (2003) 378-384
18. Bevan R.J., Durand M.F., Hickenbotham P.T., et al. Validation of a novel ELISA for measurement of MDA-LDL in human plasma. Free Radic Biol Med 35 (2003) 517-527
19. Mashiba S., Wada Y., Takeya M., et al. In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL. Arterioscler Thromb Vasc Biol 21 (2001) 1801-1808
20. Ogasawara K., Mashiba S., Wada Y., et al. A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease. Atherosclerosis 174 (2004) 349-356
21. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., and Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98 (1998) 1487-1494
22. Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 844-848
23. Hatch F.T. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6 (1968) 1-68
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
25. Hermo R., Mier C., Mazzotta M., Tsuji M., Kimura S., and Gugliucci A. Circulating levels of nitrated apolipoprotein A-I are increased in type 2 diabetic patients. Clin Chem Lab Med 43 (2005) 601-606
26. Shao B., Bergt C., Fu X., et al. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 280 (2005) 5983-5993
27. Seghrouchni I., Drai J., Bannier E., et al. Oxidative stress parameters in type I, type II and insulin-treated type II diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 321 (2002) 89-96
28. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., and Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280 (2001) E685-E694
29. Jay D., Hitomi H., and Griendling K.K. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40 (2006) 183-192